Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Impaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation.

Shabir S, Kaul B, Pachnio A, Banham GD, Smith H, Chand S, Jham S, Harper L, Ball S, Rahbar A, Söderberg-Nauclér C, Moss P, Borrows R.

J Am Soc Nephrol. 2013 Oct;24(10):1698-708. doi: 10.1681/ASN.2013040340. Epub 2013 Jul 11.

2.

Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection.

Christmas SE, Halliday D, Lawton N, Wang H, Abdalla I, Masters J, Hassan RL, Hart IJ, Khan N, Smith J, Hammad A, Bakran A.

Transpl Immunol. 2009 Dec;22(1-2):99-104. doi: 10.1016/j.trim.2009.07.003. Epub 2009 Jul 24.

PMID:
19635559
3.

Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.

Ganepola S, Gentilini C, Hilbers U, Lange T, Rieger K, Hofmann J, Maier M, Liebert UG, Niederwieser D, Engelmann E, Heilbronn R, Thiel E, Uharek L.

Bone Marrow Transplant. 2007 Mar;39(5):293-9. Epub 2007 Jan 29.

PMID:
17262060
4.

Donor serostatus has an impact on cytomegalovirus-specific immunity, cytomegaloviral disease incidence, and survival in seropositive hematopoietic cell transplant recipients.

Ugarte-Torres A, Hoegh-Petersen M, Liu Y, Zhou F, Williamson TS, Quinlan D, Sy S, Roa L, Khan F, Fonseca K, Russell JA, Storek J.

Biol Blood Marrow Transplant. 2011 Apr;17(4):574-85. doi: 10.1016/j.bbmt.2010.07.020. Epub 2010 Aug 3.

5.

A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection.

Eid AJ, Brown RA, Arthurs SK, Lahr BD, Eckel-Passow JE, Larson TS, Razonable RR.

Transpl Int. 2010 May 1;23(5):506-13. doi: 10.1111/j.1432-2277.2009.01017.x. Epub 2009 Nov 27.

PMID:
19951371
6.

Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.

Zhou W, Longmate J, Lacey SF, Palmer JM, Gallez-Hawkins G, Thao L, Spielberger R, Nakamura R, Forman SJ, Zaia JA, Diamond DJ.

Blood. 2009 Jun 18;113(25):6465-76. doi: 10.1182/blood-2009-02-203307. Epub 2009 Apr 15.

7.

Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant.

López-Oliva MO, Martinez V, Buitrago A, Jiménez C, Rivas B, Escuin F, Santana MJ, Selgas R, Bellón T.

Transplantation. 2014 Apr 27;97(8):839-45. doi: 10.1097/01.TP.0000438025.96334.eb.

PMID:
24345896
8.

Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients.

Egli A, Binet I, Binggeli S, Jäger C, Dumoulin A, Schaub S, Steiger J, Sester U, Sester M, Hirsch HH.

J Transl Med. 2008 Jun 9;6:29. doi: 10.1186/1479-5876-6-29.

9.

High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.

Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P.

Transpl Immunol. 2009 Mar;20(4):238-42. doi: 10.1016/j.trim.2008.11.002. Epub 2008 Nov 24.

PMID:
19032982
10.
11.

Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.

Hughes D, Hafferty J, Fulton L, Friend P, Devaney A, Loke J, Welsh KI, Handa A, Klenerman P.

J Clin Virol. 2008 Feb;41(2):92-5. Epub 2007 Nov 26.

12.

T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.

Popescu I, Pipeling MR, Shah PD, Orens JB, McDyer JF.

J Immunol. 2014 Dec 1;193(11):5709-22. doi: 10.4049/jimmunol.1401436. Epub 2014 Oct 22.

13.

Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.

Lin TS, Zahrieh D, Weller E, Alyea EP, Antin JH, Soiffer RJ.

Transplantation. 2002 Jul 15;74(1):49-54.

PMID:
12134098
14.

Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection.

Sester M, Sester U, Gärtner BC, Girndt M, Meyerhans A, Köhler H.

J Am Soc Nephrol. 2002 Oct;13(10):2577-84.

15.

Rapid T cell repopulation after rabbit anti-thymocyte globulin (rATG) treatment is driven mainly by cytomegalovirus.

Havenith SH, Remmerswaal EB, Bemelman FJ, Yong SL, van Donselaar-van der Pant KA, van Lier RA, Ten Berge IJ.

Clin Exp Immunol. 2012 Sep;169(3):292-301. doi: 10.1111/j.1365-2249.2012.04622.x.

16.

Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation.

Gandhi MK, Wills MR, Okecha G, Day EK, Hicks R, Marcus RE, Sissons JG, Carmichael AJ.

Blood. 2003 Nov 1;102(9):3427-38. Epub 2003 Jul 17.

17.

Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.

Cummins NW, Deziel PJ, Abraham RS, Razonable RR.

Transpl Infect Dis. 2009 Feb;11(1):20-7. doi: 10.1111/j.1399-3062.2008.00344.x. Epub 2008 Sep 21.

PMID:
18811629
19.

Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells.

Komatsu H, Kogawa K, Nonoyama S, Inui A, Sogo T, Fujisawa T, Klenerman P.

J Med Virol. 2006 Dec;78(12):1616-23.

PMID:
17063516
20.

Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants.

Reusser P, Attenhofer R, Hebart H, Helg C, Chapuis B, Einsele H.

Blood. 1997 May 15;89(10):3873-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk